Anika Therapeutics, Inc.
ANIK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $56 | $69 | $86 | $94 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $24 | $26 | $35 | $30 |
| Inventory | $24 | $24 | $40 | $36 |
| Other Curr. Assets | $11 | $44 | $9 | $8 |
| Total Curr. Assets | $114 | $163 | $170 | $169 |
| Property Plant & Equip (Net) | $65 | $65 | $79 | $69 |
| Goodwill | $7 | $8 | $7 | $8 |
| Intangibles | $2 | $3 | $75 | $82 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $1 | $1 | $1 | $0 |
| Other NC Assets | $14 | $31 | $17 | $20 |
| Total NC Assets | $89 | $107 | $180 | $179 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $203 | $271 | $349 | $348 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $9 | $8 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $1 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $22 | $16 | $20 |
| Total Curr. Liab. | $23 | $31 | $28 | $30 |
| LT Debt | $24 | $26 | $29 | $19 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $6 | $10 |
| Other NC Liab. | $1 | $1 | $0 | $1 |
| Total NC Liab. | $25 | $27 | $36 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $26 | $28 | $31 | $21 |
| Total Liabilities | $49 | $58 | $64 | $60 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $72 | $128 | $211 | $226 |
| AOCI | -$7 | -$6 | -$6 | -$6 |
| Other Equity | $89 | $90 | $81 | $67 |
| Total Equity | $154 | $212 | $286 | $287 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $203 | $271 | $349 | $348 |
| Net Debt | -$30 | -$41 | -$55 | -$73 |